Patents Assigned to SORBAOONE UNIVERSITE
  • Patent number: 11512294
    Abstract: The disclosure pertains to the field of molecular means capable of binding to, and preferably of chelating, cGMP, appropriate for use in vitro or in vivo and preferably capable of targeting specific cellular compartments. The polypeptides of the disclosure comprise a chimeric construction derived from the N terminus part of PKG-I? and PKG-I?, and the two cGMP binding sites of the wild type PKG.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: November 29, 2022
    Assignees: SORBAOONE UNIVERSITE, CENTRE NATIONAL DE LA RECHARCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET LA RECHERCHE MEDICALE (INSERM)
    Inventors: Xavier Nicol, Oriol Ros Torres